Pesticide-induced systemic scleroderma: a case report

Read full text Summarise with VIRAT
Authors: Olga A. Georginova, E. A. Grishanina, Antonina A. Michurina, Макаров Егор Алексеевич, В Г Авдеев, Leonid Aleksandrovich Strizhakov, Tatyana N. Krasnova, Elena M. Seredenina
Cited by: 0
References: 55

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Systemic sclerosis, or systemic scleroderma, is a rare autoimmune connective tissue disease. The presented clinical case highlights that taking an occupational history is essential in patients with suspected systemic connective tissue diseases for early detection of autoimmune disorders caused by occupational exposures and timely elimination of adverse environmental factors. This article discusses the pathophysiological mechanisms by which pesticides may induce immune disorders, promoting systemic scleroderma. CLINICAL CASE DESCRIPTION: This article presents a case of systemic scleroderma caused by prolonged occupational exposure to pesticides (cypermethrin, bromadiolone, and chlorpyrifos) used for rodent control. The condition manifested as triphasic Raynaud disease, as confirmed by nailfold capillaroscopy findings. This was followed by skin induration on the face, arms, and trunk, with a baseline modified Rodnan skin score of 28, polyarthralgia, and interstitial lung disease. Immunological tests revealed a high titer of antinuclear antibodies (1:1280) and anti-topoisomerase I antibodies (Scl-70), which was consistent with systemic scleroderma. The disease had a fluctuating course, with exacerbations following intercurrent viral infections. Immunosuppressive therapy with glucocorticoids and cytostatic agents (methotrexate, cyclophosphamide, mycophenolate mofetil) resulted in disease stabilization, with partial regression of cutaneous and visceral symptoms. CONCLUSION: The unfavorable prognosis in the presented clinical case is associated with the chronic, progressive course of the disease, with a high risk of disability, deterioration in quality of life, and decrease in life expectancy. However, timely diagnosis and adequate pathogenetic therapy can considerably delay the progression of fibrotic changes and improve the prognosis.

Fields of Study & Subjects

Systemic Sclerosis and Related Diseases Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Inflammatory Myopathies and Dermatomyositis

Publication details

Journal / source
Journal of clinical practice
Volume
17
Issue
2
Pages
196–206
Publication date
19 March 2026
Language
EN